Shanghai ERP Biotechnology: difference between revisions
Diff·revision 12 → 13·07:15, 6 Oct 2025
Difference between revision 12 and revision 13 of Shanghai ERP Biotechnology. 3 lines changed; the page grew by 284 bytes.
| Revision 12 — 10:29, 23 Sep 2025 BatchNumberBede (talk) correct the trading name — the short code and the legal name are different things 6,476 bytes +144 | Revision 13 — 07:15, 6 Oct 2025 BlindSampleBrid (talk) label the reception tally as weak, self-selected evidence at this point of use 6,760 bytes +284 | ||
|---|---|---|---|
| 49 | The catalogue follows the sector pattern, and the distinguishing feature is documentary rather than in the range: [[Bacterial endotoxin test|endotoxin]] results appear in submissions about this organisation and in almost none about the others covered here, and the determination is issued against a named lot on request.{{r|selfpub,reports}} | 49 | The catalogue follows the sector pattern, and the distinguishing feature is documentary rather than in the range: [[Bacterial endotoxin test|endotoxin]] results appear in submissions about this organisation and in almost none about the others covered here, and the determination is issued against a named lot on request.{{r|selfpub,reports}} |
| 50 | 50 | ||
| + | 51 | == Independent testing record == | |
| + | 52 | Submitted reports on ERP material to July 2026 are concentrated on the incretin range. Reported [[Area percent purity|area percent]] figures have clustered in the high nineties, consistent with accompanying certificates where available.{{r|reports}} | |
| + | 53 | ||
| 51 | == References == | 54 | == References == |
| 52 | {{reflist}} | 55 | {{reflist}} |